Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Tokyo, Japan, that manufactures pharmaceutical products for gastrointestinal disease.

Bengbu Fengyuan Pharmaceutical Technology Dev Co. Ltd., a subsidiary of Anhui Fengyuan Pharmaceutical Co., Ltd., is a company headquartered in Bengbu, China, that manufactures and distributes pharmaceuticals, food additives and other chemicals. Anhui Fengyuan Pharmaceutical Co., Ltd. acquired Bengbu Fengyuan Pharmaceutical Technology Dev Co. Ltd. from Anhui Fengyuan Group Holding Co., Ltd. on April 30, 2012 for $1.14 million.

Hainan MeilanShiKline Pharmaceutical Co., Ltd., established on 2002-01-24, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;property management(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

2018 was a significant year for Hyundai Pharmaceutical to receive AA rating, the highest level in the pharmaceutical industry, in recognition of the effective operation of the Fair Trade Compliance Program. Since the Fair Trade Compliance Program was introduced in 2007, they have consistently announced top management's willingness to comply, regular training for their employees, reward rules for the best, and strict sanctions for violators. Has been trying to take root in culture. In recent years, legal and institutional regulations on fair trade and anti-corruption have been tightened, and the level of punishment has also increased. All employees must do their best to maintain a fair market order and prevent any type of risk that may arise from personal careless behavior.

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceutical preparations, raw materials, pharmaceutical excipients, plant extracts, anti-infective drugs, anti-allergic drugs, digestive system drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, gynecological drugs, tonics, and topical plasters. The company was founded on January 19, 2001 and is headquartered in Changsha, China.

Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd., established on 1993-07-05, The business scope includes production and operation within the scope of the drug production license;Foreign trade operation;Realtor;Space lease;road freight transport:road general cargo transportation(Operate with a valid license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Ruicheng Hongqiao Pharmaceutical Intermediates Co., Ltd., established on 2001-08-09, The scope of business includes the manufacture of organic chemical raw materials(Hazardous Chemicals,precursor chemicals,National law,Except for special approvals required by regulations and decisions of the State Council);Agricultural and sideline products,Chinese herbal medicine processing and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)******

Qingdao Chenda Biotechnology Co., Ltd., established on 2015-04-01, Business scope includes pharmaceutical products,medical instruments,medical equipment,Green facilities,Sanitary materials and accessories,Chemical raw materials(Does not contain dangerous goods),Technology development of health food and health products,Technical Services,technology transfer,Technical consultation, maintenance and installation;General consumer goods economic information consultation;Biotechnology Information Consulting. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Bengbu Fengyuan Tushan Pharmaceutical Co., Ltd., established on 2008-09-03, The scope of business includes large-volume injections,powder injection,tablet,Granules,hard capsule,transdermal patch,Powder,Psychotropic drugs(Zaleplon Tablets)production,operate;Pharmaceutical Intermediates,Production of packaging materials,Sales;drug research,to develop;disinfection products,Production of masks,Sales.The following limited branch operations:API,Psychotropic drugs(Zaleplon),Production and operation of pharmaceutical excipients.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mochida Pharmaceutical is a drug manufacturing company. Their pharmaceutical business aims to develop and market a broad spectrum of innovative new drugs. They also offer creates skin care products for the general public, and these are supplied through pharmacies, and drugstores.

Pharmirae Co., Ltd. is a private company headquartered in the South Korea. The firm wholesales chemicals and chemical products.

Hunan Pudao Pharmaceutical Technology Co., Ltd., established on 2008-05-19, The scope of business includes chemical engineering research services;Food Science and Technology Research Services;Chemical product research and development;Research and development of plant extracts;Medical Research and Experimental Development;drug development;Research and development of biological products;Medical Device Technology Development;Medical device technical consultation,communication service;Medical device technology transfer service;Technology intermediary service;Science and Technology Information Consulting Services;Technology project agency service;Technical Market Management Services;Scientific literature service;Biotechnology Development Services,consult,communication service,transfer service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

UCB Japan produces and supplies pharmaceutical products for diseases in the areas of neurology, the immune system, and inflammation. Their products include antiepileptic drugs, anti-rheumatoid arthritis and psoriasis drugs, and more. The company's contact modes are by phone and physical address.

Chengdu Speika Technology Co., Ltd., established on 2016-04-19, Business scope includes research and development,Sales:Computer hardware and software,electronic product;Computer Network Technology Consulting Services;Advertising Design,make,acting,release(Excluding balloon advertisements and fixed-form print advertisements);Cultural exchange event planning;Enterprise Marketing Planning;Conference and exhibition service;Business Management Consulting;Business Consulting;Sales:Office supplies and consumables,sporting goods,daily necessities,furniture,tea set,Stationery,lamps,household appliances,digital product.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Weihai Life Group engages in pharmaceutical production. It has passed the GMP certification of the national pharmaceutical production standards. The company has modern production equipment, strict management systems, and advanced management methods.

Danyang Heng'an Chemical Technology Research Institute Co., Ltd., established on 2009-06-30, Business scope includes medicinal chemistry,Product development and technology transfer of materials chemistry,Chemical Products(except dangerous goods)Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)